While the three biotech penny stocks highlighted in today’s article are risky, each of these under-$5 plays has earned a Moderate or Strong Buy consensus rating from analysts – and […]
read more
Why This “Picks And Shovels” Stock Could Be A Better COVID-19 Play Than Moderna
Moderna could strike gold when it comes to its COVID-19 vaccine candidate – or it could flop. Either way, the under-the-radar “picks-and-shovels” stock highlighted in today’s article – one that […]
read more
Its Diabetes-Delaying Drug Could Be A Game-Changer For This Under-The-Radar Biotech
What makes the clinical-stage biotech highlighted in today’s article, one focused on developing drugs to prevent certain diseases, worth strongly considering? Its most exciting drug candidate seeks to delay the […]
read more
The Top-Performing Biotech Stocks Last Week (Thanks To Their Coronavirus Vaccine Candidates)
What did the two top-performing biotech stocks last week have in common? As you might expect, and as today’s article notes, “They both delivered positive press releases regarding their respective […]
read more
Why Consider These 3 Biotech Stocks? “Products, Products, And More Products”!
When it comes to picking biotech stocks, the author of today’s article declares “I can’t help favoring those with strong, late-stage pipelines and at least one promising or successful drug […]
read more
A Trade Idea For This Immunotherapy Stock That Appears Set To Surge
The innovative clinical-stage immunotherapy company highlighted in today’s article has a slew of bullish indicators, suggesting it’s gearing up for a surge – and the author outlines one trade idea […]
read more
10 Top Ideas From The “Rich Pocket” Of Penny Stocks
Unlike institutional investors, who are typically prevented from owning them, individual investors are able to access penny stocks – and their potentially explosive returns. Noting that “Penny stock trading is […]
read more
Electoral Options: How – And Why – Traders Are Pricing In A Lot Of Risk In Early November
Despite the rejuvenated “risk-on” tone in the market at the moment, today’s article notes that traders are pricing in a lot of risk at one particular point in time in […]
read more
Why Now May Be The Perfect Time To Buy This Biotech Stock – And Avoid This Other One
“A crucial aspect of success in investing in biotech stocks is that of timing,” notes the author of today’s article, who proceeds to examine one biotech stock where it appears […]
read more
Seeking Abnormal Returns In “The New Abnormal”
As uncertain as things are right now, the author of today’s article advises that there are several categories of companies that will move higher in the current stock market: companies […]
read more